Relmada Therapeutics: Leerink Partners upgrades to Outperform, raises PT to $8.

viernes, 23 de enero de 2026, 7:17 am ET1 min de lectura
RLMD--

Relmada Therapeutics: Leerink Partners upgrades to Outperform, raises PT to $8.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios